SPRUCE BIOSCIENCES, INC. (SPRB)

↓ Download CSV

CIK 0001683553 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, SPRUCE BIOSCIENCES, INC. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $53.02M in total assets against $10.51M in total liabilities.

Key ratios (FY2025)

-91.7%
Return on equity
-100.0%
Revenue growth (YoY)
Metric (FY)20252024202320222021202020192018
Revenue$0$4.91M$10.09M$0
Operating Income-$36.51M-$56.15M-$51.99M-$47.28M-$42.07M-$29.42M-$13.11M
Net Income-$38.97M-$53.04M-$47.92M-$46.18M-$42.29M-$29.54M-$13.09M
EPS (Diluted)$-50.83$-96.40$-1.24$-1.96$-1.81
Total Assets$53.02M$45.21M$103.95M$85.65M$126.49M$162.88M$4.69M
Total Liabilities$10.51M$16.39M$27.44M$17.16M$15.12M$13.46M$7.52M
Shareholders' Equity$42.52M$28.82M$76.51M$68.49M$111.37M$149.43M-$30.64M-$17.80M
Cash & Equivalents$48.91M$38.75M$96.34M$24.49M$42.75M$157.15M$3.92M
Operating Cash Flow-$33.33M-$55.96M-$33.27M-$41.68M-$35.88M-$27.52M-$12.62M
Capital Expenditures$0$7.0K$8.0K$93.0K$74.0K$4.0K
Shares Outstanding1.37M563.0K41.03M23.60M23.49M23.26M764.4K